Cite
HARVARD Citation
de Castro, T. et al. (2022). Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience. Therapeutic advances in medical oncology. p. . [Online].